What is the address of HECAM?

The registered office of HECAM is located at Jan Van Looylaan(Kok) 5, 8670 Koksijde.

Is HECAM still active?

Yes. According to the CBE (30 October 2026) HECAM is active, legal situation “Normale toestand”, started on 20 July 2009.

Is HECAM registered on Peppol?

Yes, HECAM is registered on the Peppol network with ID 0208:0817226087.

What is the enterprise number of HECAM?

The enterprise number of HECAM is BE0817226087.

When was HECAM founded?

HECAM was founded on 20 July 2009.

Who are the directors of HECAM?

According to the 2026 annual accounts, the directors of HECAM are: Kris Baes.

Is HECAM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 July 2009; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did HECAM make in 2026?

HECAM posted a profit after taxes of € 2,610 in financial year 2026.

What is the revenue of HECAM?

As a small company, HECAM is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 25,008.

HECAM (Private Limited) - Koksijde - BE0817226087

Dossier HECAM, printed on 30 October 2026 from databakkes.be/en/0817226087/hecam. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 5 % of short-term debt in 2026; threshold 65 %.

Financials

Financial year 2026

HECAM from Koksijde, company number BE0817226087, closed financial year 2026 with a result of € 2,610 after tax. For that financial year HECAM recorded a gross margin of € 25,008 and equity of € 0. Compared with financial year 2025, the result moved from € 30,545 to € 2,610. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 9, 2026.

What it is worth Caution

€ 0

▼ 100% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 2,610

▼ 91% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 40,834

▲ € 34,203 vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 255,128 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 89,170 Gross margin 2023: € 89,170 First fiscal year in the series	€ 10,835 Gross margin 2024: € 10,835 ▼ 88% vs 2023 (€ 89,170) Unfavourable step	€ 65,325 Gross margin 2025: € 65,325 ▲ € 54,490 vs 2024 (€ 10,835) Favourable step	€ 25,008 Gross margin 2026: € 25,008 ▼ 62% vs 2025 (€ 65,325) Unfavourable step	▼ 62%
Profit after taxes	€ 29,171 Profit after taxes 2023: € 29,171 First fiscal year in the series	€ -25,073 Profit after taxes 2024: € -25,073 ▼ € 54,243 vs 2023 (€ 29,171) Unfavourable step	€ 30,545 Profit after taxes 2025: € 30,545 ▲ € 55,617 vs 2024 (€ -25,073) Favourable step	€ 2,610 Profit after taxes 2026: € 2,610 ▼ 91% vs 2025 (€ 30,545) Unfavourable step	▼ 91%
Equity	€ 397,046 Equity 2023: € 397,046 First fiscal year in the series	€ 371,973 Equity 2024: € 371,973 ▼ 6% vs 2023 (€ 397,046) Unfavourable step	€ 402,517 Equity 2025: € 402,517 ▲ 8% vs 2024 (€ 371,973) Favourable step	€ 0 Equity 2026: € 0 ▼ 100% vs 2025 (€ 402,517) Unfavourable step	▼ 100%
Total debts	€ 471,160 Total debts 2023: € 471,160 First fiscal year in the series	€ 471,121 Total debts 2024: € 471,121 Unchanged (€ 471,160) Favourable step	€ 464,249 Total debts 2025: € 464,249 ▼ 1% vs 2024 (€ 471,121) Favourable step	€ 819,834 Total debts 2026: € 819,834 ▲ 77% vs 2025 (€ 464,249) Unfavourable step	▲ 77%
Cash	€ 5,123 Cash 2023: € 5,123 First fiscal year in the series	€ 4,134 Cash 2024: € 4,134 ▼ 19% vs 2023 (€ 5,123) Unfavourable step	€ 6,631 Cash 2025: € 6,631 ▲ 60% vs 2024 (€ 4,134) Favourable step	€ 40,834 Cash 2026: € 40,834 ▲ € 34,203 vs 2025 (€ 6,631) Favourable step	▲ € 34,203
Retained profit	€ 247,046 Retained profit 2023: € 247,046 First fiscal year in the series	€ 221,973 Retained profit 2024: € 221,973 ▼ 10% vs 2023 (€ 247,046) Unfavourable step	€ 252,517 Retained profit 2025: € 252,517 ▲ 14% vs 2024 (€ 221,973) Favourable step	€ 0 Retained profit 2026: € 0 ▼ 100% vs 2025 (€ 252,517) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2023: € 0 First fiscal year in the series	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged	€ 255,128 Dividend 2026: € 255,128 Unchanged (€ 0) Unchanged
Balance sheet total	€ 868,206 Balance sheet total 2023: € 868,206 First fiscal year in the series	€ 843,094 Balance sheet total 2024: € 843,094 ▼ 3% vs 2023 (€ 868,206) Unchanged	€ 866,766 Balance sheet total 2025: € 866,766 ▲ 3% vs 2024 (€ 843,094) Unchanged	€ 819,834 Balance sheet total 2026: € 819,834 ▼ 5% vs 2025 (€ 866,766) Unchanged	▼ 5%

Key figures of HECAM, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 17 October 2027.

What happened to HECAM?

What happened at HECAM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 9, 2026 New annual accounts for financial year 2026: profit of € 2,610 (▼ 91% vs 2025). Source: NBB ↗
2024 Kris Baes became a director. NBB
Jul 20, 2009 Start of the company according to the CBE. KBO

In short

From € 29,171 profit in 2023 to € 2,610 profit in 2026.

Best year ever: 2025, with € 30,545 profit.

Paid out € 255,128 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Kris Baes

HECAM

XMED

NUPHAR TECH

Nascendi

Behind HECAM is Kris Baes. Kris Baes is also behind XMED, NUPHAR TECH, Nascendi, BAES-BLANCKAERT and UNIPHARM.

Directors

According to the 2026 annual accounts

Kris Baes

Director

Also active at: XMED, NUPHAR TECH, Nascendi, BAES-BLANCKAERT, UNIPHARM

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Jan Van Looylaan(Kok) 5

8670 Koksijde

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

XMED same network

€ 40,016 gross margin · 2025

NUPHAR TECH same network

€ -53,085 gross margin · 2025

Nascendi same network

€ -25,294 gross margin · 2025

BAES-BLANCKAERT same network

€ 71,536 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0817.226.087
VAT number: BE 0817.226.087
Registered office: Jan Van Looylaan(Kok) 5, 8670 Koksijde
Names & denominations: HECAM
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 July 2009
Peppol: Active · Active since 14 May 2025

View on CBE Public ↗ Annual accounts (NBB) ↗